PGI Chandigarh Cancels Medical Officer Interview Schedule 2020 Due To COVID-19
Chandigarh - In the light of the rising coronavirus cases in the UT, Postgraduate Institute of Medical Education and Research Chandigarh (PGI Chandigarh) has cancelled the Interview Schedule for Medical Officer Posts.
All such candidates who have to appear for the Medical Officer Interview Schedule can check the notification available on the official website of PGIMER -http://pgimer.edu.in/
Postgraduate Institute of Medical Education and Research (PGIMER) has released the short notification which says, " This is in the reference to the for the post of Medical Officer Project Title: "Strengthening Evidence-based Family Planning Service in Pre-service Medical Education" Department of Community Medicine & School of Public Health, PGIMER, Chandigarh were is cancelled due to COVID19. It is for the information of all concerned that the Interview scheduled on 30th April, 2020 for the above said post is cancelled."
You can check the notification with the direct link given below.
https://.in/pdf_upload/pdf_upload-127995.pdf
Read Also: PGI Chandigarh team that performed re-implantation surgery on Punjab cop to be honoured
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
0 Comments
Post a comment
No comments yet. Be the first to comment!